This Medudy course is a short conference report for physicians on the topic of "ESGO 2026: Annual Congress for Gynecological Oncology" featuring the AI avatar of Prof. Dr. Fabian Trillsch, Deputy Director of the Clinic and Polyclinic for Gynecology and Obstetrics at LMU Hospital in Munich.
This short video summarizes some of the most important highlights of the congress and provides an assessment of their clinical relevance. It presents the final results of the follow-up phase of the KEYNOTE-B96 study on the treatment of platinum-resistant recurrent ovarian cancer, supplemented by data on the quality of life of patients. This is followed by the final results of the ICON-8B study, which investigated the efficacy of dose-dense chemotherapy in advanced ovarian cancer. In addition, a retrospective analysis of the data regarding the selection of patients with a poor prognosis is presented. In the last part, KORE-INNOVATION is discussed in relation to perioperative therapy support for ovarian cancer.
Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.
At the end of this training you will know:
- Some of the highlights of ESGO 2026
- the most important findings of the studies presented
- The expert's conclusion on the studies presented
